Image de couverture de livre

ATM defects result in Xist modulation.

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Deletion of repeat B and C of Xist results in induction of SATB1.
par: Mamoor, Shahan
Publié: (2026)

Telomerase control of Xist through Trf2.
par: Mamoor, Shahan
Publié: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
par: Mamoor, Shahan
Publié: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
par: Mamoor, Shahan
Publié: (2025)

An epigenetic module common to the T lymphocyte.
par: Mamoor, Shahan
Publié: (2026)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
par: Mamoor, Shahan
Publié: (2026)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
par: Mamoor, Shahan
Publié: (2026)

NLRP7 engagement in transformation and etiology of chronic disease.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
par: Mamoor, Shahan
Publié: (2025)

Importin 8 is activated in childhood brain cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
par: Mamoor, Shahan
Publié: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
par: Mamoor, Shahan
Publié: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
par: Mamoor, Shahan
Publié: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
par: Mamoor, Shahan
Publié: (2025)

HSC, CMP and CLP in mice.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
par: Mamoor, Shahan
Publié: (2025)

Aire is a component gene of the Th17 gene signature.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: INPP5F.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
par: Mamoor, Shahan
Publié: (2025)

FCGRT functions in senescence and transformation.
par: Mamoor, Shahan
Publié: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
par: Mamoor, Shahan
Publié: (2025)

Leukotriene activation in the blood of humans with high CRP.
par: Mamoor, Shahan
Publié: (2025)

TSC22D4 gene activation in Crohn's Disease.
par: Mamoor, Shahan
Publié: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
par: Mamoor, Shahan
Publié: (2025)

Genes expressed in the CD4 + T lymphocyte.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: ATG13.
par: Mamoor, Shahan
Publié: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
par: Mamoor, Shahan
Publié: (2025)

Ribosomal activation in TNBC resistance in vitro.
par: Mamoor, Shahan
Publié: (2025)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
par: Mamoor, Shahan
Publié: (2025)

SSX2IP induction in basal subtype breast cancer.
par: Mamoor, Shahan
Publié: (2025)